Single-blind randomised controlled phase 1a trial of the safety and immunogenicity of lyophilised recombinant precipitated tropical malaria vaccine (BK-SE36) in Japan.
Phase of Trial: Phase I
Latest Information Update: 20 Sep 2016
At a glance
- Drugs Malaria vaccine (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions
- 05 Jan 2010 New trial record